Clinical Trial Update: Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day [Phase 3]

View source ↗

Summary

A phase 3 trial assessing 3-day versus 5-day regimens of artemether-lumefantrine for Plasmodium falciparum infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Infection

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Falciparum Infection | Phase 3 | Status: COMPLETED